Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEuropean regulators approve GlaxoSmithKlines Avamys
Corporate News Releases - The Healthcare Sales & Marketing Network, 01/16/08
The European Commission granted marketing authorisation to GlaxoSmithKline’s allergic rhinitis drug, Avamys, the drugmaker announced Tuesday. The treatment is the first intranasal corticosteroid to show "consistently significant improvements" in both nose and eye allergy symptoms, the drugmaker noted
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Drug Approval Summary: Bevacizumab (Avastin) as Treatment of Recurrent Glioblastoma Multiforme
The Oncologist, 12/03/09
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Sponsor
Article Search
Sponsor